Straits Times Index
3,330.01 -8.93 (-0.27%) S&P 500
5,347.97 +56.63 (+1.07%) Dow
38,804.56 +93.27 (+0.24%) Nasdaq
17,158.20 +301.15 (+1.79%) Bitcoin USD
70,996.20 +449.89 (+0.64%) CMC Crypto 200
1,522.17 +48.43 (+3.29%)
CLDX Jan 2025 25.000 call
| Previous close | 23.41 |
| Open | 22.65 |
| Bid | 18.80 |
| Ask | 21.40 |
| Strike | 25.00 |
| Expiry date | 2025-01-17 |
| Day's range | 22.65 - 23.41 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
GlobeNewswireCelldex Therapeutics to Present at Jefferies Healthcare Conference
HAMPTON, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 6th at 10:00 am ET. A webcast of the presentation will be available on the "Events & Presentations” page of the "Investors & Media" section of the Celldex website. A replay will be available for 90 days following the event. About Celldex Therapeutics, Inc.Celldex is a clinical stage b
- GlobeNewswire
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2024
- Clinically meaningful and statistically significant improvements across multiple angioedema measurements and barzolvolimab dose groups -- Sustained activity with rapid onset within 2 weeks -- Data further support barzolvolimab clinical benefit to patients with CSU - HAMPTON, N.J., June 02, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced data demonstrating that barzolvolimab profoundly improves angioedema at 12 weeks in the Company’s Phase 2 clinical trial in c
ZacksWall Street Analysts Think Celldex (CLDX) Could Surge 87.27%: Read This Before Placing a Bet
The mean of analysts' price targets for Celldex (CLDX) points to an 87.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
